Ambu Q1 2024/25 Results Earnings

Ambu reported strong Q1 2024/25 results with 19.5% organic revenue growth and 16.1% EBIT margin. The company raised full-year guidance to 11-14% revenue growth and 13-15% EBIT growth, driven by solid performance in pulmonology and urology/ENT/GI segments.